<DOC>
	<DOCNO>NCT01880151</DOCNO>
	<brief_summary>Recent diagnostic criterion Alzheimer 's disease ( AD ) recognize extend spectrum AD stag part disease , include preclinical stage . This underscore importance early prognosis AD still possible influence course disorder . The investigator propose comprehensive project target data-driven modeling disease development . This goal achieve create validate battery new sensitive biomarkers clinical evaluation prediction AD individual . The AD-related brain change assess noninvasive functional EEG measure episodic memory task subject different stage AD , well healthy control . The novel functional biomarkers extract use rigorous multistage selection procedure involve advanced method feature extraction , well statistic classification optimal selection . The ESTIMATE project serve first step extensive array research procedures enable early clinical identification Alzheimer 's disease elderly individual could take advantage preventive pharmaceutical therapy .</brief_summary>
	<brief_title>Neuroelectrical Biomarkers Alzheimer 's Disease Stages</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Age : 7085 year old Presence memory impairment Completed educational level : middle school Visual auditory acuity : normal correctedtonormal Monogenic AD Presence neurological disorder Stroke occur last three month Prohibited medication Residence skilled nursing facility Illiteracy , unable count read Claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Dementia</keyword>
	<keyword>Prodromal</keyword>
	<keyword>EEG</keyword>
	<keyword>ERP</keyword>
	<keyword>Biomarkers</keyword>
</DOC>